Department of Photodynamic Therapy

• Development of photosensitizers and photon-source–enabled platforms, and the pharmaceutical development of these agents via nanobiotechnology.
• Advancement and optimization of photodynamic reactions—inactivation, diagnostic, and therapeutic—through modeling and experimental studies.
• Development of preclinical/clinical applications and combination therapies (e.g., radiotherapy, chemotherapy) integrated with photodynamic therapy.

• Indigenization of therapies for hard-to-treat diseases (e.g., cancers, Alzheimer’s disease) and application of photodynamic methods with antibacterial effects for the management of chronic wounds.
• Identification of concurrent combination regimens—e.g., chemotherapy + photodynamic therapy (PDT)—to enhance therapeutic efficacy.
• Design of novel drug candidates leveraging emerging technologies and investigation of their photodynamic effects.
• Design of drug-delivery systems based on new technological platforms and evaluation of their impact on PDT performance.

• Collaborative research projects: Joint projects with scientific institutions and universities.
• Supervision of student theses: Advising graduate research aligned with the Department’s focus areas.

• Clinical translation of photodynamic technologies.
• Production of photosensitizing agents based on nanobiotechnology.
• Introduction of plant-derived photodynamic applications.